Related Experiment Videos
[A platypnea-orthodeoxia syndrome]
F Haziza1, J F Landau, M Francoual
1Service de cardiologie, hôpital Foch, 40, rue Worth, BP 36, 92151 Suresnes. f.haziza@hopital-foch.org
Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 5, 2003
Summary
Platypnea orthodeoxia syndrome in a 68-year-old patient was successfully treated by closing a patent foramen ovale (PFO) using a percutaneous transcatheter device, resolving symptoms.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Platypnea orthodeoxia syndrome (POS) is a rare condition characterized by dyspnea that worsens when upright and improves when supine.
- It is often associated with intrapulmonary shunting, commonly due to a patent foramen ovale (PFO).
Observation:
- A 68-year-old patient presented with symptoms suggestive of POS, with varying oxygen saturation based on body position.
- Transthoracic and transesophageal echocardiography (TEE) confirmed a right-to-left shunt through a patent foramen ovale.
Findings:
- Right heart angiography corroborated the echocardiographic findings and guided the procedure.
- Percutaneous transcatheter closure of the PFO was successfully performed using a Cardioseal device.
- Post-procedure, the patient's symptoms resolved completely.
Implications:
- This case highlights the effectiveness of percutaneous PFO closure for treating POS.
- Transcatheter device implantation offers a minimally invasive option for managing this complex syndrome.
- Successful closure leads to significant symptom improvement and enhanced quality of life.